Summary
[Yaben Chemical: did not supply caron anhydride products to Pfizer]Yaben Chemical announced on the evening of February 6 that the company’s response to the letter of concern disclosed on January 5 stated that “Caron acid anhydride and its derivative products from the process flow Can be used to synthesize Pfizer’s new crown oral drug Palo Verde”, in which caron anhydride and its derivative products refer to compounds, rather than products produced by the company. New crown oral medicine. (Interface News)
Masamoto ChemistryFebruary 6 eveningannouncement, the company’s response to the letter of concern disclosed on January 5 stated that “Caron anhydride and its derivative products can be used in the synthesis ofPfizerThe company’s new crown oral drug Palo Verde”, in which caron anhydride and its derivative products refer to compounds, rather than products produced by the company.PfizerNew crown oral medicine.company withPfizerThe company has no business contacts and cooperation, has not signed a cooperation agreement with Pfizer, and has not supplied caron anhydride products to Pfizer. Pfizer has not provided the company with any quality standards for the procurement of front-end raw materials for new crown oral drugs, and the company’s customers refused to provide Purchasing the final use of the company’s caron anhydride and its derivative products, the company cannot determine whether the caron anhydride products produced meet the needs of Pfizer’s products, and has not carried out relevant technical verification to determine whether the caron anhydride products produced by the company are or can become Pfizer’s new crown oral drug intermediate.
(Article source: Interface News)